SCHEMBL7713432

SCHEMBL7713432

CC1=C(N)Nc2cc(C(N)(Cc3ccc(S(C)(=O)=O)cc3)C(=O)OC(C)(C)C)ccc2O1

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.34
EPHX2 P34913 1/20 0.32
NR1H4 Q96RI1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7710746 0.93 CA2 (0.34) EPHX2NR1H4
SCHEMBL7711363 0.91 EPHX2 (0.30) EPHX2
SCHEMBL7708186 0.90
SCHEMBL7704963 0.88 CYP3A4 (0.34)
SCHEMBL7708351 0.88
SCHEMBL7704909 0.88 MMP8 (0.31)
SCHEMBL7704944 0.87 ALDH1A1 (0.32) EPHX2NR1H4
SCHEMBL7708348 0.87 NR1D1 (0.35)
SCHEMBL7711326 0.86 GAA (0.30)
SCHEMBL7711304 0.84 CYP3A4 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed